Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence

The obesity pandemic is accompanied by increased risk of developing metabolic syndrome (MetS) and related conditions: non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), type 2 diabetes mellitus (T2DM) and cardiovascular (CV) disease (CVD). Lifestyle, as well as an imbala...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Emir M. Muzurović MD, MM (Autor), Špela Volčanšek MD (Autor), Karin Zibar Tomšić MD, PhD (Autor), Andrej Janež MD, PhD (Autor), Dimitri P. Mikhailidis MD (Autor), Manfredi Rizzo MD, PhD (Autor), Christos S. Mantzoros MD (Autor)
Formato: Livro
Publicado em: SAGE Publishing, 2022-12-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Número de Chamada: A1234.567
Cópia 1 Disponível